tiprankstipranks
BioAdaptives (BDPT)
OTHER OTC:BDPT
US Market
BDPT
BioAdaptives
RESEARCH TOOLSreports

BioAdaptives (BDPT) Ratios

24 Followers

BioAdaptives Ratios

BDPT's free cash flow for Q2 2026 was $0.85. For the 2026 fiscal year, BDPT's free cash flow was decreased by $ and operating cash flow was $-39.53. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.04 0.09 0.15 0.05 0.02
Quick Ratio
 0.02 0.07 0.14 0.04 0.02
Cash Ratio
 0.02 0.07 0.08 0.03 0.02
Solvency Ratio
 -0.59 -0.66 -0.52 -0.39 -0.56
Operating Cash Flow Ratio
 -0.15 -0.22 -0.14 -0.13 -0.15
Short-Term Operating Cash Flow Coverage
 -0.54 -1.34 -0.73 -0.68 -0.58
Net Current Asset Value
$ -1.78M$ -2.14M$ -1.46M$ -1.66M$ -1.45M
Leverage Ratios
Debt-to-Assets Ratio
 6.64 1.70 1.31 3.17 10.51
Debt-to-Equity Ratio
 -0.30 -0.18 -0.23 -0.20 -0.27
Debt-to-Capital Ratio
 -0.42 -0.22 -0.31 -0.25 -0.37
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 -0.04 -0.11 -0.18 -0.06 -0.03
Debt Service Coverage Ratio
 -1.66 -2.27 -1.33 -1.06 -0.80
Interest Coverage Ratio
 -3.57 -14.70 -6.55 -1.41 -1.46
Debt to Market Cap
 31.09 1.73 0.70 0.73 6.16
Interest Debt Per Share
 0.05 0.05 0.05 0.08 0.96
Net Debt to EBITDA
 -0.38 -0.22 -0.35 -0.52 -0.67
Profitability Margins
Gross Profit Margin
74.48%68.37%31.81%37.88%41.49%
EBIT Margin
-5366.65%-8135.56%-4610.39%-1925.43%-3528.18%
EBITDA Margin
-5049.76%-5658.02%-4595.07%-1823.91%-3167.21%
Operating Profit Margin
-3551.11%-5701.79%-4751.76%-801.68%-2456.92%
Pretax Profit Margin
-4553.73%-8523.35%-7141.53%-2492.56%-5216.58%
Net Profit Margin
-4553.73%-8523.35%-7096.06%-2492.56%-5216.58%
Continuous Operations Profit Margin
-4553.73%-8523.35%-7096.06%-2492.56%-5216.58%
Net Income Per EBT
100.00%100.00%99.36%100.00%100.00%
EBT Per EBIT
128.23%149.49%150.29%310.92%212.32%
Return on Assets (ROA)
-1477.75%-689.64%-343.28%-684.63%-2401.24%
Return on Equity (ROE)
62.10%73.14%61.41%43.24%61.73%
Return on Capital Employed (ROCE)
51.40%48.93%41.12%13.91%29.07%
Return on Invested Capital (ROIC)
73.00%59.70%53.66%17.38%39.83%
Return on Tangible Assets
-1477.75%-689.64%-343.28%-804.00%-2610.42%
Earnings Yield
-5125.85%-699.85%-182.38%-158.97%-1408.67%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 4.52 0.00 0.00
Payables Turnover
 0.25 0.43 1.44 5.41 1.45
Inventory Turnover
 0.18 0.13 0.45 1.16 0.00
Fixed Asset Turnover
 2.32 1.31 0.00 0.00 0.00
Asset Turnover
 0.32 0.08 0.05 0.27 0.46
Working Capital Turnover Ratio
 -0.01 -0.01 >-0.01 -0.02 -0.01
Cash Conversion Cycle
 546.88 1.97K 634.82 246.78 -252.01
Days of Sales Outstanding
 0.00 0.00 80.67 0.00 0.00
Days of Inventory Outstanding
 2.02K 2.82K 807.61 314.30 0.00
Days of Payables Outstanding
 1.47K 853.18 253.46 67.52 252.01
Operating Cycle
 2.02K 2.82K 888.28 314.30 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.05 -0.03 -0.04 -0.32
Free Cash Flow Per Share
 -0.02 -0.05 -0.03 -0.04 -0.32
CapEx Per Share
 0.00 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.03 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 -28.67 -83.17K 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 -28.67 -83.17K 0.00 0.00
Operating Cash Flow Coverage Ratio
 -0.54 -1.34 -0.73 -0.68 -0.58
Operating Cash Flow to Sales Ratio
 -10.97 -28.23 -19.70 -7.83 -13.23
Free Cash Flow Yield
-1459.94%-239.90%-50.62%-49.96%-357.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.01 -0.15 -0.55 -0.63 -0.07
Price-to-Sales (P/S) Ratio
 0.66 12.18 38.91 15.68 3.70
Price-to-Book (P/B) Ratio
 -0.01 -0.10 -0.34 -0.27 -0.04
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.06 -0.42 -1.98 -2.00 -0.28
Price-to-Operating Cash Flow Ratio
 -0.07 -0.43 -1.98 -2.00 -0.28
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.07 <0.01 <0.01
Price-to-Fair Value
 -0.01 -0.10 -0.34 -0.27 -0.04
Enterprise Value Multiple
 -0.40 -0.43 -1.20 -1.37 -0.79
Enterprise Value
 512.72K 448.59K 698.55K 716.28K 430.24K
EV to EBITDA
 -0.40 -0.43 -1.20 -1.37 -0.79
EV to Sales
 20.06 24.54 55.14 25.08 25.05
EV to Free Cash Flow
 -1.83 -0.84 -2.80 -3.20 -1.89
EV to Operating Cash Flow
 -1.83 -0.87 -2.80 -3.20 -1.89
Tangible Book Value Per Share
 -0.12 -0.21 -0.18 -0.28 -2.06
Shareholders’ Equity Per Share
 -0.12 -0.21 -0.18 -0.28 -2.05
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 <0.01 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 0.02
Net Income Per Share
 -0.08 -0.15 -0.11 -0.12 -1.27
Tax Burden
 1.00 1.00 0.99 1.00 1.00
Interest Burden
 0.85 1.05 1.55 1.29 1.48
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 36.11 57.48 39.85 7.41 21.36
Stock-Based Compensation to Revenue
 4.11 24.27 16.49 0.00 0.00
Income Quality
 0.74 0.33 0.28 0.31 0.25
Currency in USD